This site is intended for Healthcare Professionals only.

Pharmanovia appoints Nivedita Valentine as VP of Product Innovation


Share post:

The life cycle management company, Pharmanovia, has appointed Nivedita Valentine as associate vice president of Product Innovation.

Ms Valentine will oversee the company’s product innovation operations and decision-making as Pharmanovia continues to focus efforts on both, identifying new prospects to enhance lifecycle management of its brands through incremental innovation. She will report to interim chief scientific officer Stephen Deacon and help bridge unmet patient needs with the help of novel therapies, originating both from in-house development and through partnerships.

Ms Valentine currently holds  positions on the value-added medicines committee within Medicines for Europe and the International Rare Diseases Research Consortium (IRDiRC) Task Force on Drug Repurposing Guidebook.

Pharmanovia CEO Dr James Burt commented: “Digitalization and utilizing the latest technological innovation are notable areas of acceleration within the pharma industry and Nivedita’s appointment will ensure iconic brands will continue to be improved, supported, and used sustainably.

“I am delighted to welcome Nivedita to Pharmanovia as we continue the next phase of our strategic growth journey.”

Backed by more than fifteen years of leadership experience, Ms Valentine brings deep market knowledge and technical expertise to Pharmanovia’s product innovation division. Previously she has held global senior management positions at Accord Healthcare and Glenmark Pharmaceuticals.

Commenting on her new role, Ms Valentine said: “Pharmanovia is at an incredibly exciting point within its growth journey, rapidly establishing its position as a leader in life cycle management with a strong, innovative pipeline.

“I’m excited to take on this role within such a committed, patient-centered organization with an incredibly talented, like-minded team who constantly seek to identify new ways to enhance the lives of the patients.”



Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

RPS makes Maudsley Deprescribing Guidelines available for RPS members

The Royal Pharmaceutical Society (RPS) has alerted free access to pharmacy members about a new addition to their...

Community pharmacists lead Pharmacy First digital launch

New pharmacy first platform, My Local Surgery, to connects patients with clinical services provided by community pharmacists  Community pharmacists...

CCA members celebrate hitting 200,000 Pharmacy First consultations milestone

Along with the pharmacy first celebrations, the Company Chemists Association has also highlighted the urgent need for GP...

General Election 2024: Political parties’ manifestos for community pharmacy

Political parties vow to expand the role of community pharmacy, alleviate financial strain, and establish a more sustainable...